Siyuan Shen Selected Research

tabersonine

8/2022

Tabersonine attenuates Angiotensin II-induced cardiac remodeling and dysfunction through targeting TAK1 and inhibiting TAK1-mediated cardiac inflammation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Siyuan Shen Research Topics

Disease

6	Neoplasms (Cancer) 07/2022 - 01/2021
4	Choroidal Neovascularization 01/2018 - 01/2014
3	Macular Degeneration (Age-Related Maculopathy) 01/2018 - 01/2014
2	Inflammation (Inflammations) 08/2022 - 01/2021
2	Fibrosis (Cirrhosis) 08/2022 - 12/2020
2	Ovarian Neoplasms (Ovarian Cancer) 07/2022 - 05/2022
2	Vascular Remodeling 01/2021 - 12/2020
1	Heart Failure 08/2022
1	Carcinogenesis 07/2022
1	Hypoxia (Hypoxemia) 01/2022
1	Crohn Disease (Crohn's Disease) 12/2021
1	Ulcerative Colitis 12/2021
1	Colorectal Neoplasms (Colorectal Cancer) 12/2021
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 12/2021
1	Autistic Disorder (Autism) 10/2021
1	Bipolar Disorder (Manic Depressive Psychosis) 10/2021
1	Psychotic Disorders (Schizoaffective Disorder) 10/2021
1	Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder) 10/2021
1	Uterine Cervical Neoplasms (Cancer of the Cervix) 07/2021
1	Esophageal Neoplasms (Esophageal Cancer) 01/2021
1	Vascular System Injuries 12/2020
1	Hypertension (High Blood Pressure) 12/2020
1	Retinal Diseases 01/2017
1	Vascular Diseases (Vascular Disease) 01/2017
1	Shock 10/2015
1	Necrosis 10/2015
1	Burns 09/2014
1	Corneal Neovascularization 01/2014
1	Infections 06/2006
1	Viremia 10/2005

Drug/Important Bio-Agent (IBA)

5	Proteins (Proteins, Gene)FDA Link 07/2022 - 10/2005
4	Biomarkers (Surrogate Marker)IBA 12/2021 - 01/2021
2	Angiotensin IIIBA 08/2022 - 12/2020
2	Toll-Like Receptor 2IBA 12/2020 - 01/2014
2	Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA 01/2018 - 12/2015
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2017 - 12/2015
1	p38 Mitogen-Activated Protein KinasesIBA 08/2022
1	tabersonineIBA 08/2022
1	CaspasesIBA 07/2022
1	sharpinIBA 07/2022
1	Messenger RNA (mRNA)IBA 07/2022
1	Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA 05/2022
1	Pharmaceutical PreparationsIBA 01/2022
1	Drug CombinationsIBA 01/2022
1	RNA (Ribonucleic Acid)IBA 01/2022
1	Antipsychotic Agents (Antipsychotics)IBA 10/2021
1	Toll-Like Receptor 4IBA 01/2021
1	Indicators and Reagents (Reagents)IBA 01/2021
1	acrizanibIBA 01/2018
1	Peptides (Polypeptides)IBA 01/2017
1	Retinaldehyde (Retinal)IBA 01/2017
1	Ranibizumab (Lucentis)FDA Link 01/2017
1	afliberceptIBA 01/2017
1	SteroidsIBA 10/2015
1	Dexamethasone (Maxidex)FDA LinkGeneric 10/2015
1	cobra venom factorIBA 09/2014
1	Small Interfering RNA (siRNA)IBA 09/2014
1	Complement System Proteins (Complement)IBA 09/2014
1	Anaphylatoxin C5a ReceptorIBA 09/2014
1	Complement Receptors (Complement Receptor)IBA 09/2014
1	Myeloid Differentiation Factor 88IBA 01/2014
1	Neutralizing AntibodiesIBA 06/2006
1	Aligeron (AS 2)IBA 06/2006
1	env Gene ProductsIBA 06/2006
1	DNA (Deoxyribonucleic Acid)IBA 10/2005
1	VaccinesIBA 10/2005

Therapy/Procedure

8	Therapeutics 07/2022 - 12/2015
2	Lasers (Laser) 09/2014 - 01/2014
1	Drug Therapy (Chemotherapy) 01/2022
1	Duration of Therapy 10/2021
1	Immunotherapy 01/2021
1	Intravitreal Injections 01/2018
1	Topical Administration 01/2018
1	Light Coagulation 09/2014